S-Phenyl-N-Acetylcysteine.

Glutathione is built from cysteine, glutamate and glycine, and a cysteine-donating compound only fills one of those three slots. Glycine supply becomes the limiting step once cysteine is plentiful, particularly with age.

Glutamate is joined to cysteine by glutamate-cysteine ligase in the first committed step of glutathione assembly. A cysteine donor pushes that step, and glutamate is what it pushes against.

Glutathione peroxidase carries selenium in its active site and is the enzyme that uses reduced glutathione to neutralise peroxides. More cysteine raises the substrate; selenium determines how fast the enzyme can use it.

Glutathione reductase is an FAD enzyme, and FAD is made from riboflavin. Without adequate riboflavin the oxidised glutathione formed during antioxidant work is returned to its active form more slowly.

Dihydrolipoic acid reduces oxidised glutathione back to its active thiol form and independently raises cellular cysteine uptake. The two thiol systems regenerate each other.

Glutathione reduces the ascorbyl radical back to ascorbate, and ascorbate in turn spares glutathione during oxidative load. Raising cysteine supply keeps that exchange running in both directions.

Free thiols bind copper ions with high affinity, which is the same chemistry behind N-acetylcysteine's metal-binding behaviour. Regular high-dose thiol intake alongside copper can lower how much copper stays available.

Glutathione supplies the thiol that attacks the electrophile, and everything downstream is the stepwise trimming of that tripeptide. Gamma-glutamyl transpeptidase removes glutamate, a dipeptidase removes glycine, and N-acetyltransferase acetylates the remaining cysteine to give the mercapturic acid. Glutathione availability is therefore the first constraint on the whole route. This is settled phase two biochemistry that needs no citation.

Glutamate cysteine ligase is the committed step in glutathione synthesis and cysteine is normally the scarce substrate, not glutamate or glycine. Where cysteine supply is short, glutathione pools fall and conjugation capacity falls with them. This is textbook amino acid biochemistry. It supports normal phase two conjugation capacity and says nothing about any exposure outcome.

Homocysteine derived from methionine condenses with serine through cystathionine beta-synthase, and cystathionine gamma-lyase then releases cysteine. That route is how dietary methionine becomes glutathione substrate. The relationship is established one-carbon and sulfur biochemistry. It supports normal sulfur amino acid supply.

Cystathionine beta-synthase and cystathionine gamma-lyase each require pyridoxal 5-phosphate at the active site. Without adequate B6 the flow from methionine to cysteine slows, and cysteine is what limits glutathione synthesis. The cofactor requirement is textbook enzymology needing no citation. It supports normal sulfur amino acid metabolism.

Nrf2 activation raises expression of glutamate cysteine ligase and of several GST isoforms, the two things that determine how much conjugation capacity a cell has. Mercapturic acid output rises with that capacity, which is why urinary mercapturates are used as readouts in Nrf2 research. Higher output of a marker reflects processing, not harm avoided. The induction mechanism is documented in cell and animal work.

The glucosinolate itself is inactive until myrosinase from the plant or from gut bacteria releases the isothiocyanate. Once formed, sulforaphane drives the same Nrf2 induction of conjugation enzymes. Extracts vary widely in whether active myrosinase survived processing, which is the practical variable. The relationship to mercapturate formation is mechanistic rather than an outcome.

Cysteine dioxygenase diverts cysteine toward cysteine sulfinate and on to taurine, a branch point that runs parallel to glutathione synthesis. Where taurine synthesis is active, less cysteine reaches glutamate cysteine ligase. Supplying taurine directly spares that route rather than competing with it. Both directions are established sulfur amino acid biochemistry.

Sulfur from cysteine that is not incorporated into glutathione or taurine ends as sulfite, and sulfite oxidase converts that to sulfate for excretion using a molybdopterin cofactor. Adequate molybdenum keeps that terminal step running. This is textbook trace element biochemistry. It supports normal sulfur handling rather than any effect on the phenyl conjugate itself.

SAM-e is an allosteric activator of cystathionine beta-synthase, which means rising SAM-e pushes homocysteine down the transsulfuration branch toward cysteine rather than back toward methionine. That regulatory switch is how the cell decides between remethylation and cysteine production. The relationship is established one-carbon biochemistry. It supports normal sulfur amino acid partitioning.

Methylenetetrahydrofolate reductase and methionine synthase send homocysteine back toward methionine, while cystathionine beta-synthase sends it toward cysteine. The two branches draw on the same pool and the balance shifts with folate status and with SAM-e. Calling this competitive describes a real partition, not a problem. It is settled one-carbon metabolism.

Betaine donates a methyl group to homocysteine independently of folate and B12, which reduces the homocysteine available to the transsulfuration branch. That branch is the one that makes cysteine for glutathione. As with folate, the competition is a normal regulatory partition rather than an adverse interaction. It supports normal homocysteine handling.

Hepatic glutathione is the substrate pool that GST enzymes draw on when conjugating electrophiles, and silymarin has been reported to preserve that pool in animal and cell work. Human data are thinner and largely marker based. The connection to phenyl conjugate formation is mechanistic inference, not measurement. It supports normal hepatic antioxidant status.

Metallothionein is roughly one third cysteine by residue count, so induction pulls appreciably on cysteine supply. Where zinc intake is high and cysteine supply is marginal, the two demands compete. The induction relationship is well documented; the size of the competing draw in a normally fed person is not established. Read it as a mechanistic consideration.